Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Tislelizumab can cause cutaneous lupus erythematosus.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Intense Pulsed Light is an effective and safe hair removal method for people with excessive hair growth.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.